Pages that link to "Q24298056"
Jump to navigation
Jump to search
The following pages link to Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status (Q24298056):
Displaying 50 items.
- Coactivator associated arginine methyltransferase 1 (Q5008826) (← links)
- Transcriptional activation of human matrix metalloproteinase-9 gene expression by multiple co-activators (Q24289430) (← links)
- Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer (Q24670460) (← links)
- Arginine methyltransferases as novel therapeutic targets for breast cancer (Q26851594) (← links)
- Structural basis for CARM1 inhibition by indole and pyrazole inhibitors (Q27666983) (← links)
- Roles of protein arginine methyltransferases in the control of glucose metabolism (Q28087448) (← links)
- The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer (Q28387891) (← links)
- Protein arginine methylation in mammals: who, what, and why (Q29617309) (← links)
- Distinct pigmentary and melanocortin 1 receptor-dependent components of cutaneous defense against ultraviolet radiation (Q33269159) (← links)
- Enzymatic activity is required for the in vivo functions of CARM1. (Q33569642) (← links)
- Differential CARM1 expression in prostate and colorectal cancers (Q33576367) (← links)
- PRMT8 demonstrates variant-specific expression in cancer cells and correlates with patient survival in breast, ovarian and gastric cancer. (Q33599084) (← links)
- Epigenetics: an emerging player in gastric cancer (Q33718259) (← links)
- Xenoestrogens regulate the activity of arginine methyltransferases (Q33796036) (← links)
- CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells (Q33899490) (← links)
- Chemical and biochemical approaches in the study of histone methylation and demethylation (Q34030702) (← links)
- Identification of small-molecule enhancers of arginine methylation catalyzed by coactivator-associated arginine methyltransferase 1. (Q34456824) (← links)
- A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression. (Q34987904) (← links)
- Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin (Q35033872) (← links)
- Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene (Q35037230) (← links)
- Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax. (Q35101485) (← links)
- Selective inhibitors of protein methyltransferases (Q35135783) (← links)
- Protein arginine methyltransferase 7 promotes breast cancer cell invasion through the induction of MMP9 expression (Q35550160) (← links)
- Chemical biology of protein arginine modifications in epigenetic regulation (Q35722457) (← links)
- Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases. (Q36080362) (← links)
- Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer (Q36088933) (← links)
- Targeting epigenetic regulatory mechanisms in cancer chemoprevention (Q36150848) (← links)
- Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells. (Q36581678) (← links)
- A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases (Q36703511) (← links)
- Biologic agents as adjunctive therapy for prostate cancer: a rationale for use with androgen deprivation (Q36731130) (← links)
- The therapeutic uses of chromatin-modifying agents (Q36822457) (← links)
- Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity (Q36874135) (← links)
- Chemical mechanisms of histone lysine and arginine modifications (Q37097824) (← links)
- Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes (Q37153775) (← links)
- Protein arginine methylation in health and disease (Q37209124) (← links)
- Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays. (Q37410839) (← links)
- Protein methyltransferases as a target class for drug discovery (Q37590090) (← links)
- Protein arginine methyltransferases: nuclear receptor coregulators and beyond (Q37726342) (← links)
- Small molecule modulators of histone acetylation and methylation: A disease perspective (Q37796326) (← links)
- Targets in epigenetics: inhibiting the methyl writers of the histone code (Q37941687) (← links)
- Protein arginine methyltransferases (PRMTs) as therapeutic targets (Q38012526) (← links)
- Protein Arginine Methyltransferases (PRMTs): promising targets for the treatment of pulmonary disorders. (Q38064312) (← links)
- Protein arginine methyltransferases and cancer (Q38067063) (← links)
- Protein arginine methylation of non-histone proteins and its role in diseases (Q38168045) (← links)
- Role of PRMTs in cancer: Could minor isoforms be leaving a mark? (Q38219647) (← links)
- Progress and challenges in predicting protein methylation sites. (Q38529273) (← links)
- Histone modifying enzymes: novel disease biomarkers and assay development (Q38691865) (← links)
- Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs (Q38707876) (← links)
- Inhibitors of Protein Methyltransferases and Demethylases. (Q38740496) (← links)
- Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response (Q38895538) (← links)